Neuroepithelial, Perineurial, and Schwann Cell Neoplasm

Neuroepithelial, Perineurial, and Schwann Cell Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,131 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 101–107 of 107 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05664243	A Phase 1b / 2 Drug Resistant Immunotherapy With Activated, Gene Modified Allogeneic or Autologous γδ T Cells (DeltEx) in Combination With Maintenance Temozolomide in Subjects With Recurrent or Newly Diagnosed Glioblastoma	active not recruiting	Phase 1 / Phase 2	4	In8bio Inc.INDUSTRY	1	May 1, 2025	clinicaltrials
NCT04881032	AGuIX Nanoparticles With Radiotherapy Plus Concomitant Temozolomide in the Treatment of Newly Diagnosed Glioblastoma(NANO-GBM)	active not recruiting	Phase 1 / Phase 2	66	Centre Jean PerrinOTHER